한국유니온제약
2,410KRWMarket close of 10/20 (Tue)
No trade that dayMarket close of 10/20 (Tue)
- Volume
- 0×10K shares
- 0 KRW
Open, high and low are not shown — the source has no bar for the reference date
Market close of 10/20 (Tue)
Where it sits in the 1-year range
7%7% of the way up from the lowest close in 1 year (252 sessions) · -57.6% from the high
Something to check
2 to check: no trades this day · operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveto checkNo trades this day (0 shares)
- Earningsto check-17.0B KRWOperating income over the last four quarters -17.0B KRW (loss)
- Trading valuenot verifiedNo trading that day, so not compared with usual trading value
The other 3
- Recent filingsnot verified
- Foreign & institutionalnot verified
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue5.9B KRW
- vs. year ago
- -53.2%
- vs. prior quarter
- -9.0%
- Operating income-1.6B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-26.5%
- vs. year ago
- -12.4 pp
- vs. prior quarter
- +14.3 pp
Quarterly operating income trend
As of the latest official close · 2026-10-20Valuation filing date · 2026-05-14Same sector · 제약
Down -1.68%· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +11.4% | Down -0.40% | 139.2B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -1.3% | Down -2.52% | 129.9B KRW |
| 삼익제약 | Close over the last 20 sessions -20.4% | Up +2.77% | 76.0B KRW |
| 녹십자엠에스 | Close over the last 20 sessions +30.5% | Up +6.67% | 55.6B KRW |
| 유한양행 | Close over the last 20 sessions +11.5% | Down -1.37% | 41.6B KRW |
Schedule
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.